Listed on GrantGunner. Last checked 10 Jul 2026.
About this grant
Non-dilutive funding of up to $1 million for Australian SMEs, startups, and spin-outs developing medical devices to prevent, diagnose, treat, or manage cardiovascular disease and diabetes complications. Provides acceleration support, with cash co-contribution required and applications closing 30 March 2026.
Who can apply
Australian small to medium enterprises (SMEs), including spin-outs and start-ups, working on medical devices for cardiovascular disease and diabetes complications.